Welcome to the UPF Digital Repository

The functional impact of alternative splicing in cancer

Show simple item record

dc.contributor.author Climente González, Héctor
dc.contributor.author Porta-Pardo, Eduard
dc.contributor.author Godzik, Adam
dc.contributor.author Eyras Jiménez, Eduardo
dc.date.accessioned 2017-09-28T11:22:20Z
dc.date.available 2017-09-28T11:22:20Z
dc.date.issued 2017
dc.identifier.citation Climente-González H, Porta-Pardo E, Godzik A, Eyras E. The functional impact of alternative splicing in cancer. Cell Rep. 2017 Aug 29; 20(9): 2215-2226. DOI: 10.1016/j.celrep.2017.08.012
dc.identifier.issn 2211-1247
dc.identifier.uri http://hdl.handle.net/10230/32830
dc.description.abstract Alternative splicing changes are frequently observed in cancer and are starting to be recognized as important signatures for tumor progression and therapy. However, their functional impact and relevance to tumorigenesis remain mostly unknown. We carried out a systematic analysis to characterize the potential functional consequences of alternative splicing changes in thousands of tumor samples. This analysis revealed that a subset of alternative splicing changes affect protein domain families that are frequently mutated in tumors and potentially disrupt protein-protein interactions in cancer-related pathways. Moreover, there was a negative correlation between the number of these alternative splicing changes in a sample and the number of somatic mutations in drivers. We propose that a subset of the alternative splicing changes observed in tumors may represent independent oncogenic processes that could be relevant to explain the functional transformations in cancer, and some of them could potentially be considered alternative splicing drivers (AS drivers).
dc.description.sponsorship H.C.-G. and E.E. were supported by the MINECO and FEDER (BIO2014-52566-R), Consolider RNAREG (CSD2009-00080), AGAUR (SGR2014-1121), the European ITN Network RNP-Net (ID: 289007), and the Sandra Ibarra Foundation for Cancer (FSI2013). E.P.-P. and A.G. were supported by the SBP CC grant (P30 CA030199). All authors thank The Cancer Genome Atlas project for making their data publicly available. The Computational RNA Biology Group is part of the Research Programme on Biomedical Informatics (GRIB), which is a member of ELIXIR-Excelerate of the European Union Horizon 2020 Programme 2014-2020 (No. 676559) and of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023 of the PE I+D+I 2013-2016, funded by ISCIII and FEDER
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Elsevier
dc.rights © 2017 Héctor Climente-González et al. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject.other Càncer
dc.title The functional impact of alternative splicing in cancer
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1016/j.celrep.2017.08.012
dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/BIO2014-52566-R
dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/CDS2009-00080
dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/289007
dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/676559
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion


This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

Compliant to Partaking